Grant: Discovery Grants Program - Individual
University of Toronto
$26,000.00
Molecular Interactions that modulate PI3 Kinase and MAP Kinase pathways during apoptosis
EF 2013-14
Résumé
When injured, central nervous system (CNS: brain and spinal cord) neurons initiate a carefully orchestrated ""suicide"" program, called apoptosis. The elements that control this suicide program are conserved throughout different species and observed in a wide variety of human diseases of the CNS. Research has lead to a more complete understanding of the mechanisms of apoptosis during development of CNS in lower animals. However, relatively little is known about this process in adult mammalian CNS neurons. My objective is to develop an understanding of the triggers and mechanisms of apoptosis in the adult mammalian CNS, using the optic nerve transection model in the visual system. Optic nerve transection results in the apoptotic death of 90% of retinal ganglion cells (RGCs) within 14 days. This model system is also advantageous because RGC axon regeneration, within the normally non-permissive CNS, can also be examined after optic nerve crush. We are studying the regulation of two pathways that prevent neuron apoptosis: the phosphoinositide-3 kinase (PI3K) and mitogen activated protein kinase (MAPK) pathways. We have identified several proteins (PTEN, Erbin, Bcr) that antagonize the activity of these pathways, and developed peptide antagonists to block this endogenous inhibitory activity. In the future, we will use these inhibitory peptides to reveal how PTEN, Erbin and Bcr regulate cell death. We have also recently identified a pro-apoptotic role for proteins in the RIP family (receptor interacting proteins). Our long term studies will characterize how RIPs fit into the apoptotic hierarchy using our unique mammalian models of adult neuron apoptosis. Our studies will bridge the knowledge gap between mammalian species and lower animals where apoptosis has been more clearly defined. This is an important development towards understanding numerous diseases of the CNS in humans, where apoptosis is the primary mechanism of neuron degeneration.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
355802-2012
Name nom
Koeberle, Paulo
Department département
Surgery
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
2
Nb partie
5
Application title
Molecular Interactions that modulate PI3 Kinase and MAP Kinase pathways during apoptosis
Keyword
NSERC
Application summary
When injured, central nervous system (CNS: brain and spinal cord) neurons initiate a carefully orchestrated ""suicide"" program, called apoptosis. The elements that control this suicide program are conserved throughout different species and observed in a wide variety of human diseases of the CNS. Research has lead to a more complete understanding of the mechanisms of apoptosis during development of CNS in lower animals. However, relatively little is known about this process in adult mammalian CNS neurons. My objective is to develop an understanding of the triggers and mechanisms of apoptosis in the adult mammalian CNS, using the optic nerve transection model in the visual system. Optic nerve transection results in the apoptotic death of 90% of retinal ganglion cells (RGCs) within 14 days. This model system is also advantageous because RGC axon regeneration, within the normally non-permissive CNS, can also be examined after optic nerve crush. We are studying the regulation of two pathways that prevent neuron apoptosis: the phosphoinositide-3 kinase (PI3K) and mitogen activated protein kinase (MAPK) pathways. We have identified several proteins (PTEN, Erbin, Bcr) that antagonize the activity of these pathways, and developed peptide antagonists to block this endogenous inhibitory activity. In the future, we will use these inhibitory peptides to reveal how PTEN, Erbin and Bcr regulate cell death. We have also recently identified a pro-apoptotic role for proteins in the RIP family (receptor interacting proteins). Our long term studies will characterize how RIPs fit into the apoptotic hierarchy using our unique mammalian models of adult neuron apoptosis. Our studies will bridge the knowledge gap between mammalian species and lower animals where apoptosis has been more clearly defined. This is an important development towards understanding numerous diseases of the CNS in humans, where apoptosis is the primary mechanism of neuron degeneration.